Literature DB >> 2419279

Hematological observations on Arabian SS patients with a homozygosity or heterozygosity for a beta S chromosome with haplotype #31.

A Kutlar, Y Hattori, I Bakioglu, F Kutlar, K Kamel, T H Huisman.   

Abstract

Hematological and hemoglobin composition data are presented for seven Arabian SS patients with mild disease and with high Hb F levels varying between 21 and 34%. Four patients were homozygous for a beta S chromosome with a specific haplotype (#31). The data for these four patients were similar to those for three other SS patients (and for five patients reported earlier, Ref. 2) who were heterozygous for the same beta S chromosome (#31) and for a beta S chromosome with another haplotype (mainly #19). These data offer additional evidence indicating that the increased gamma chain production is specific for the beta S chromosome with haplotype #31. The similarities in hematological data and Hb F levels between these two groups of SS patients and the normal Hb F value in Hb S heterozygotes with beta S chromosome (#31) support the suggestion that the increased Hb F production mainly occurs in response to the anemia of the sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2419279     DOI: 10.3109/03630268508997037

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  7 in total

1.  Beta S haplotypes in various world populations.

Authors:  C Oner; A J Dimovski; N F Olivieri; G Schiliro; J F Codrington; S Fattoum; A D Adekile; R Oner; G T Yüregir; C Altay
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

Review 2.  Hb F in sickle cell anemia.

Authors:  A D Adekile; T H Huisman
Journal:  Experientia       Date:  1993-01-15

3.  National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008.

Authors:  Maureen M Okam; Shimon Shaykevich; Benjamin L Ebert; Alan M Zaslavsky; John Z Ayanian
Journal:  Med Care       Date:  2014-07       Impact factor: 2.983

4.  One haplotype is associated with the Swiss type of hereditary persistence of fetal hemoglobin in the Yugoslavian population.

Authors:  G D Efremov; I Gjorgovski; N Stojanovski; J C Diaz-Chico; T Harano; F Kutlar; T H Huisman
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

Review 5.  Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine.

Authors:  Steven R Goodman; Betty S Pace; Kirk C Hansen; Angelo D'alessandro; Yang Xia; Ovidiu Daescu; Stephen J Glatt
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

6.  The levels of zeta, gamma, and delta chains in patients with Hb H disease.

Authors:  F Kutlar; J M Gonzalez-Redondo; A Kutlar; A Gurgey; C Altay; G D Efremov; K Kleman; T H Huisman
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

7.  Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.

Authors:  Li Liu; Alexander Pertsemlidis; Liang-Hao Ding; Michael D Story; Martin H Steinberg; Paola Sebastiani; Carolyn Hoppe; Samir K Ballas; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.